Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Rheumatology (Oxford, England)|July 31, 2010
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008Kimme L Hyrich, Kath D Watson, Mark Lunt, et al.
Arthritis and Rheumatism|September 2, 2006
The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradientMumtaz Patel, Alexandra M Clarke, Ian N Bruce, et al.
Arthritis Care & Research|March 19, 2016
Smoking-Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research DatalinkRebecca M Joseph, Mohammad Movahedi, William G Dixon, et al.
The Journal of Rheumatology|April 3, 2008
Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trialsAmr A Saad, Deborah P M Symmons, Peter R Noyce, et al.
Rheumatology (Oxford, England)|May 18, 2006
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterK L Hyrich, K D Watson, A J Silman, et al.
Annals of the Rheumatic Diseases|October 28, 2009
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritisTracey M Farragher, Mark Lunt, Bo Fu, et al.
Rheumatology (Oxford, England)|February 21, 2013
Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritisElizabeth M Camacho, Suzanne M M Verstappen, Jacqueline Chipping, et al.
The Journal of Investigative Dermatology|September 28, 2012
Global epidemiology of psoriasis: a systematic review of incidence and prevalenceRosa Parisi, Deborah P M Symmons, Christopher E M Griffiths, et al.
Annals of the Rheumatic Diseases|July 10, 2004
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safetyK L Hyrich, A J Silman, K D Watson, et al.
Arthritis and Rheumatism|June 1, 2006
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterKimme L Hyrich, Deborah P M Symmons, Kath D Watson, et al.
Pageof 18